EUVIMEDEUVIMED entdecken
Crossref

Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection

Mengyang Zhang, Shuyan Chen, Xiaoning Wu, Jialing Zhou, Tailing Wang, Hui Liu, Xinyan Zhao, Bingqiong Wang, Xinyu Zhao, Yuanyuan Kong, Gwyneth Shook Ting Soon, Xiaojuan Ou und 4 weitere

Journal of Medical Virology · 2023-10 · 95 (10)

DOI: 10.1002/jmv.29156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 11.10.2023. Verfasst von Mengyang Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, …. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Fatty Liver. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the increasing prevalence of steatosis in patients with chronic hepatitis B (CHB), whether the changes in steatosis impact fibrosis regression during antiviral therapy remain unclear. We aimed to identify the association between histological changes of steatosis and fibrosis in patients undergone antiviral treatment. Patients with paired liver biopsies before and after 78 weeks of antiviral therapy were enrolled in this study. Liver fibrosis was assessed by the Ishak score combined with Beijing Classification predominantly progressive, indeterminate, and predominately regressive score. Steatosis was evaluated by the nonalcoholic fatty liver disease activity score. Collagen in each site was quantitated by second harmonic generation/two photon excitation fluorescence technology. Serum proteomic changes after treatment were characterized by mass‐based spectrometry. A total of 239 CHB patients were included and divided into four groups according to the changes in steatosis: 162 (67.8%) had no steatosis throughout, 24 (10.0%) developed new‐onset steatosis, 21 (8.8%) had initial steatosis which disappeared, and 32 (13.4%) had persistent steatosis. The persistent steatosis group showed the lowest rate of fibrosis regression (14/32, 43.8%). Persistent steatosis correlated with decreased fibrosis regression significantly after adjusting for age, sex, fibrosis stage, and metabolic factors at baseline, as well as the viral response (adjusted odds ratio = 0.380, 95% confidence interval 0.145–0.996, p = 0.049). This decreased fibrosis regression was associated with accumulated collagen in the perisinusoidal area. Patients with persistent steatosis showed unique changes in glycolipid metabolism according to the serum proteomic atlas. Persistent steatosis correlated with decreased fibrosis regression during antiviral therapy in patients with CHB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicFatty LiverHumansLiverHepatitis B virusAntiviral AgentsProteomicsLiver CirrhosisFibrosisCollagen

Stichwörter der Autor:innen

antiviral therapyfatty liverhepatic fibrosishepatitis Blipid metabolism

Substanzen

Antiviral AgentsCollagen

Autor:innen und Institutionen

  • Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, Chin…
  • Department of Pathology, China-Japan Friendship Hospital, Beijing, China.
  • Department of Pathology, Beijing You-an Hospital, Capital Medical University, Beijing, China.
  • Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.
  • Department of Pathology, National University Hospital, Singapore, Singapore.
  • Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.

ORCID-Profile: Jidong Jia, Yameng Sun

Zitieren

APA

Zhang, M., Chen, S., Wu, X., Zhou, J., Wang, T., Liu, H., Zhao, X., Wang, B., Zhao, X., Kong, Y., Soon, G. S. T., Ou, X., Jia, J., Chen, W., Sun, Y., & You, H. (2023). Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection. Journal of Medical Virology, 95(10). https://doi.org/10.1002/jmv.29156

Vancouver

Zhang M, Chen S, Wu X, Zhou J, Wang T, Liu H, et al. Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection. Journal of Medical Virology. 2023;95(10). doi:10.1002/jmv.29156

BibTeX
@article{Zhang2023,
  author = {Zhang, Mengyang and Chen, Shuyan and Wu, Xiaoning and Zhou, Jialing and Wang, Tailing and Liu, Hui and Zhao, Xinyan and Wang, Bingqiong and Zhao, Xinyu and Kong, Yuanyuan and Soon, Gwyneth Shook Ting and Ou, Xiaojuan and Jia, Jidong and Chen, Wei and Sun, Yameng and You, Hong},
  title = {Persistent steatosis correlates with decreased fibrosis regression during anti‐HBV treatment in patients with chronic HBV infection},
  journal = {Journal of Medical Virology},
  year = {2023},
  volume = {95},
  number = {10},
  doi = {10.1002/jmv.29156}
}
Kostenlos starten →